Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models

Huiping Liu(California Institute for Regenerative Medicine), Manishkumar Patel(Stanford University), Jennifer A. Prescher(Stanford University), Antonia Patsialou(Albert Einstein College of Medicine), Dalong Qian(California Institute for Regenerative Medicine), Jiahui Lin(California Institute for Regenerative Medicine), Susanna Wen(California Institute for Regenerative Medicine), Ya-Fang Chang(National Yang Ming Chiao Tung University), Michael H. Bachmann(Stanford University), Yohei Shimono(California Institute for Regenerative Medicine), Piero Dalerba(California Institute for Regenerative Medicine), Maddalena Adorno(California Institute for Regenerative Medicine), Neethan A. Lobo(California Institute for Regenerative Medicine), Janet Bueno(Stanford University), Frederick M. Dirbas(Stanford University), Sumanta Goswami(Albert Einstein College of Medicine), George Somlo(City of Hope), John S. Condeelis(Albert Einstein College of Medicine), Christopher H. Contag(Stanford University), Sanjiv S. Gambhir(Stanford University), Michael F. Clarke(California Institute for Regenerative Medicine)
Proceedings of the National Academy of Sciences
October 4, 2010
Cited by 471

Abstract

To examine the role of breast cancer stem cells (BCSCs) in metastasis, we generated human-in-mouse breast cancer orthotopic models using patient tumor specimens, labeled with optical reporter fusion genes. These models recapitulate human cancer features not captured with previous models, including spontaneous metastasis in particular, and provide a useful platform for studies of breast tumor initiation and progression. With noninvasive imaging approaches, as few as 10 cells of stably labeled BCSCs could be tracked in vivo, enabling studies of early tumor growth and spontaneous metastasis. These advances in BCSC imaging revealed that CD44(+) cells from both primary tumors and lung metastases are highly enriched for tumor-initiating cells. Our metastatic cancer models, combined with noninvasive imaging techniques, constitute an integrated approach that could be applied to dissect the molecular mechanisms underlying the dissemination of metastatic CSCs (MCSCs) and to explore therapeutic strategies targeting MCSCs in general or to evaluate individual patient tumor cells and predict response to therapy.


Related Papers